1987
Blood Transfusion and Outcome in Stage III Head and Neck Carcinoma
Search citation statements
Paper Sections
Select...
42
6
5
1
Citation Types
2
21
0
0
Year Published
1988
2024
Publication Types
Select...
49
3
1
Relationship
0
53
Authors
Journals
Cited by 53 publications
(23 citation statements)
References 8 publications
2
21
0
0
“…The combination of these factors has led to allogeneic blood transfusion rates commonly exceeding 40% in patients treated for advanced head and neck cancers. [3][4][5][6][7][8]10,11 The results of this study support these findings with a transfusion rate of 82.8% for preoperatively anemic patients who received a placebo. Other clinical benefits with epoetin alfa therapy in head and neck cancer patients include improved energy level, physical activity, and overall quality of life.…”
Section: Discussion
supporting
confidence: 77%
“…The combination of these factors has led to allogeneic blood transfusion rates commonly exceeding 40% in patients treated for advanced head and neck cancers. [3][4][5][6][7][8]10,11 The results of this study support these findings with a transfusion rate of 82.8% for preoperatively anemic patients who received a placebo. Other clinical benefits with epoetin alfa therapy in head and neck cancer patients include improved energy level, physical activity, and overall quality of life.…”
Section: Discussion
supporting
confidence: 77%
“…They showed in their statistical analysis that blood transfusion increased the recurrence rate and decreased survival in patients with colorectal cancer. This finding stimulated wide research, and, later, a similar association has been observed in several other studies, especially of patients with colorectal cancer (24)(25)(26)(27)(28)(29)(30) (Table l ) , and also in patients with breast (31), lung (32,33), kidney (34)(35)(36), gastric (37), uterine cervical (38) and head and neck cancers (39) and soft tissue sarcoma (40) ( Table 2).…”
Section: 'Transplantation and Blood Transfusion
supporting
confidence: 79%
“…Studies have shown a more than two fold increase (71 vs. 31%) in recurrence of HNC, thought to be due to the immunomodulation and tumor‐promoting effects of blood transfusion 193,197–200 . Decreased OS, increased wound infections, flap failures, and hospital readmission rates were all found to be associated with perioperative blood transfusions 198,201–203 . A recent study published by Runge et al concluded that current transfusion practices do not increase oncologic risk or decrease OS over a 5 year period; however, this study included only a limited number of patients 204 …”
Section: Results
mentioning
confidence: 92%
“… 193 , 197 , 198 , 199 , 200 Decreased OS, increased wound infections, flap failures, and hospital readmission rates were all found to be associated with perioperative blood transfusions. 198 , 201 , 202 , 203 A recent study published by Runge et al concluded that current transfusion practices do not increase oncologic risk or decrease OS over a 5 year period; however, this study included only a limited number of patients. 204 …”
Section: Results
mentioning
confidence: 96%
